• Tidak ada hasil yang ditemukan

American Diabetes Association. 2011. Hyperglycemia.

http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hyperglycemia.html. Diakses pada tanggal 10 April 2012.

Antillon, D., dkk., Sex Difference in Vascular Risk Factor in a Multi-ethnic, Medically Underserved Stroke Population. Stroke 2012;43:A3358.

Brainin, M., dkk. 2010. Textbook of Stroke Medicine. New York: Cambridge University Press.

Buckley, M.B., Lipids and Stroke. British Journal of Diabetes and Vascular Disease 2003; Vol:3.

Budiarto, E. 2012.Metodologi Penelitian Kedokteran : Sebuah pengantar. Jakarta : EGC.

Caplan, L.R. 2009. Caplan’s Stroke : A Clinical Approach 4th Edition. Philadelphia : Saunders-Elsevier.

Dahlan, M.S., 2008. Statistik untuk Kedokteran dan Kesehatan: Deskriptif, Bivarian, dan Multivaran Dilengkapi Aplikasi dengan Menggunakan SPSS (Edisi 3).

Jakarta: Salemba Medika.

Dyker, A.G., Weir, C.J., Lees, K.R., Influence of cholesterol on survival after stroke:

retrospective study. BMJ 1997;314:1584.

European Atherosclerosis Society. ESC/EAS guidelines for the management of dyslipidaemias. The Task Force on the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis

Society (EAS). Atherosclerosis 2011;

doi:10.1016/j.atherosclerosis.2011.06.012

Evans, M., Robert, A., Davies, S., Rees, A., Medical Lipid-Regulating Therapy:

Current Evidence, Ongoing Trials and Future Developments. Drugs, 2004:64:1181–1196.

Garret, R.H., Grisham, C.M. 2010.Garret Biochemistry 4th Edition.Canada: Brooks-Cole.

Gillum, R.F., Gorelick, P.B., Cooper, E.S. 1999. Stroke in Clinical Neurology : A Guide in Management and Prevention.Switzerland: Karger.

39

Gofir, A. 2009. Manajemen Stroke Evidance Based Medicine. Yogyakarta: Pustaka Cendekia Press.

Gofir, A., Purwitosari, L., Wibowo, S., 2006. Suhu Tubuh Saat Masuk Sebagai Prediktor Kematian di Rumah Sakit RSUP Dr. Sardjito. Pertemuan Ilmiah Tahunan UNDIP-UNS-UGM XXI: Update Management of Neurogical Disorder and Elderly, Semarang, Badan Penerbit Universitas Diponegoro, 201.

Goldstein, L.B., dkk., Guidelines for the Primary Prevention of Stroke : A Guideline for Healthcare Professionals From the American Heart Association / American Stroke Association, Stroke 2011; 42:517-84.

Gurr, M.I. dkk. 2002. Lipid Biochemistry: an Introduction 5th Edition. Victoria:

Blackwell Science.

Hankey, G.J. 2005. Stroke Treatment and Prevention – An Evidence-Based Approach. New York: Cambridge University Press.

Harmsen, P., dkk., Long-term Risk Factrors for Stroke. Stroke 2006;37:1663-1667.

Hinkle, J.L., Guanci, M.M.Acute Ischemic Stroke Review. The Journal of Neuroscience Nursing2007;39(5): 285-293.

Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, Deborah, G., Newman, T.B., 2007. Designing Clinical Research, 3rd Edition. USA: Lippincott Williams &

Wilkins.

Khan, J., Rehman, A., Shah, A.A., Jielani, A. 2006. Frequency of Hypertension in Stroke Patients Presenting at Ayub Teaching Hospital. J Ayub Med Coll Abbottabad, 18 (1).

Kim, E., Tolhurst, A.T., Qin, L.Y., Chen, X.Y., Febbraio, M., Cho, S., CD36/Fatty Acid Translocase, An Inflammatory Mediator, IsInvolved in Hyperlipidemia-Induced Exacerbation inIschemic Brain Injury.The Journal of Neuroscience, 2008;28(18):4661– 4670.

Lamsudin, R. 1997., Algoritma Stroke Gadjah Mada – Penerapan klinis untuk membedakan stroke perdarahan intraserebral dengan stroke iskemik akut atau stroke infark, Berkala Ilmu Kedokteran, 29 (1) : 11-16.

Lehninger, A., Nelson, D.L., Cox, M.M. 2008. Lehninger-Principles of Biochemistry 4th Edition. Victoria: W.H. Freeman.

Lodish, H., dkk. 2003. Molecular Cell Biology 5th Edition. London: W.H. Freeman.

40

Makihara, N., Okada. Y., Koga, M., Shiokawa, Y., Nakagawara, J., Furui, E., Kimura, K., Yamagami, H., Hasegawa, Y., Kario, K., Okuda, S., Naganuma, M., Toyoda, K., Effect of Serum Lipid Levels on Stroke Outcome after rt-PA Therapy: SAMURAI rt-PA Registry. Cerebrovascular Disease 2012 ; 19;33(3):240-247.

Mardjono, M., Sidharta, P. 1997. Neurologi Klinis Dasar (Edisi 6). Jakarta: Dian Rakyat.

McPhee, S.J., Hammer, G.D. 2010. Pathophysiology of Disease – An Introduction to Clinical Medicine 6th Edition. McGraw-Hill: China

Mieghem, C.V., Sabbe, M., Knockaert, D. The Clinical Value of the ECG in Noncardiac Conditions. Chest 2004 125 (4): 1561–76.

Mitchel, S.V., Elkind, M.D. 2003. Stroke in The Elderly. The Mount Sinai Journal of Medicine. Volume 70, No. 1.

Mohr, J.P., dkk. 2011. Stroke Patholophysiology, Diagnosis, and Treatment 5th Edition. Philadelphia: Elsevier-Saunders.

Mumenthaler, M., Mattle, H., Taub, E. 2006. Fundamental Neurology.Stuttgart:

Thieme.

NHLBI. 2004. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - Complete Report. United States of America : NIH Publication.

Olsen, T.S., Christensen, R.H. B., Kammersgaard, L.P., Andersen, K.K., Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality. Stroke2007; 38: 2646-2651.

Piechowski-Jóźwiak, B., Bogousslavsky, J., Cholesterol as a Risk Factor for Stroke.

Stroke2004; 35: 1523-1524.

Price, S.A., Wilson, L.M. 2006. Pathophysiology Clinical Concept of Disease Processes, Volume 2 (6th ed). Pendit, dkk. 2006 (Alih Bahasa), EGC, Jakarta.

Rexrode, K.M., Emerging Risk Factor in Woman. Stroke 2009;41:S9-S11.

Ropper, A.H., Brown,R.H. 2005. Adams and Victor’s Principles of Neurology (8th Ed). United State of America: Mc Graw-Hill.

Roquer, J., Campello, A.R., Gomis, M., Ois, A., Munteis, E., Bohm, P., Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage.

Neurology 2005;65( 8):1198-1202.

41

Ryu, W.S., Lee, S.H., Kim, C.K, Kim, B.J., Yoon, B.W., Effects of low serum triglyceride on stroke mortality: A prospective follow-up study.

Atherosclerosis2010;212:299-304.

Shahar, E., Chambless, L.E., Rosamond, W.D., Boland, L.L., Ballantyne, C.M., McGovern, P.G., Sharett, A.R., Plasma Lipid Profile and Incident Ischemic Stroke. Stroke 2003 ; 34:623-631.

Teasdale, G., Jennet, B. Assessment Of Coma And Impaired Consciousness. The Lancet 1974:304:81-84.

Tsuji, H., Low Serum Cholesterol Level and Increased Ischemic Stroke Mortality.

Arch Intern Med. 2011;171(12):1116-1130.

Uyttenboogaart, M., Koch, M.W., Koopman, K., Vroomen, P.C., Luijckx, G.J., De Keyser, J., Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. Journal of Neurology 2008 ; 255(6):875-80.

Weaver, C., Nappi, A., Bodhit, A., Ju, T., Applewhite, H., Hedna, V., Waters, M., Stead, L., Prehospital GCS as a Predictor of Outcome after Acute Ischemic Stroke. Neurology2012; 78: P06.238

WHO. 2006. The Global Burder of Cerebrovascular Disease.

http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pd f.Diakses pada tanggal 7 Juni 2012.

WHO. 2009. Global Glossary of Terms and Definitions on Donation and Transplantation.http://www.who.int/transplantation/activities/GlobalGlossary onDonationTransplantation.pdf.Diakses pada tanggal 13 Juni 2012.

Wilian, I., Lennox, G. 2005. Essensial Neurology 4th Edition. Massachusetts:

Blackwell Publishing.

 

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a k_kol 1.421 .557 6.503 1 .011 4.143 1.389 12.352

Constant -2.843 .918 9.590 1 .002 .058

a. Variable(s) entered on step 1: k_kol.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a k_trigliserida .161 .690 .054 1 .815 1.175 .304 4.537

Constant -.881 .850 1.074 1 .300 .414

a. Variable(s) entered on step 1: k_trigliserida.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a k_kol_k_trig .622 .672 .856 1 .355 1.736 .499 6.955

Constant -1.426 .841 2.877 1 .090 .240

a. Variable(s) entered on step 1: k_kol_k_trig.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a l_gula 21.943 40192.908 .000 1 1.000 3.385E9 .000 .

Constant -22.682 40192.908 .000 1 1.000 .000

a. Variable(s) entered on step 1: l_gula.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a s_hipertensi 1.322 .555 5.677 1 .017 3.750 1.264 11.123

Constant -2.708 .918 8.695 1 .003 .067

a. Variable(s) entered on step 1: s_hipertensi.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a d_kesadaran 20.524 10270.962 .000 1 .998 8.191E8 .000 .

Constant -21.475 10270.962 .000 1 .998 .000

a. Variable(s) entered on step 1: d_kesadaran.

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a k_jantung .243 .599 .165 1 .685 1.275 .394 4.123

Constant -.997 .796 1.566 1 .211 .369

a. Variable(s) entered on step 1: k_jantung.

Analisis Multivariat

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

95% C.I.for EXP(B) Lower Upper

Step 1a k_kol 1.308 .577 5.136 1 .023 3.700 1.193 11.469

s_hipertensi 1.199 .579 4.292 1 .038 3.316 1.067 10.307

Constant -4.499 1.304 11.911 1 .001 .011

a. Variable(s) entered on step 1: k_kol, s_hipertensi.

LAMPIRAN

NO. VARIABEL NILAI NO.

VARIABEL

1 Nomer Pasien _ _ _ 1

2 Nama : 2

3 Rumah Sakit : RSUD SLEMAN 3

4 No. Rekam Medis 4

5 Jenis Kelamin : Laki – Laki

Perempuan [ ] 1

[ ] 2 5

6 Umur _ _ 6

7 Kelompok Umur : < 55 Tahun

> 55 Tahun [ ] 1

[ ] 2 7

8 Tanggal Masuk Rumah Sakit _ _ _ 8

9 Kadar Kolesterol _ _ _ 9

10 Kadar Kolesterol : Normal (< 240 mg/dL)

Hiperkolesterolemia (> 240 mg/dL) [ ] 1

[ ] 2 10

11 Kadar Trigliserida _ _ _ 11

12 Kadar Trigliserida : Normal (< 200 mg/dL)

Hipertrigliseridemia (> 200 mg/dL)

[ ] 1

[ ] 2 12 13 Status Hiperlipidemia : Non-Hiperlipidemia

Hiperlipidemia

[ ] 1

[ ] 2 13

14 Kadar Gula Darah _ _ _ 14

15 Level Gula Darah : Normal (< 240 mg/dL)

Hiperglikemia (> 240 mg/dL)

[ ] 1

[ ] 2 15 16 Tekanan Darah : Sistolik (mmHg)

Diastolik (mmHg)

_ _ _

_ _ _ 16

17 Status Hipertensi : Normotensi

Hipertensi [ ] 1

[ ] 2 17

18 Nilai Glasgow Coma Scale _ _ 18

19

Derajat Kesadaran : Kompos Mentis Somnolen Stupor Koma

[ ] 1 [ ] 2 [ ] 3 [ ] 4

19

20

Kelainan Jantung : Tidak ada kelainan EKG Ada kelainan EKG

[ ] 1

[ ] 2 20

21 Status Kematian : Hidup (Kontrol) Meninggal (Kasus)

[ ] 1

[ ] 2 21

 

Dokumen terkait